Showing results (71-80 of 203) with videos related to
Sort By:
Pageof 21
Statistics in Medicine|November 3, 2020
Net benefit in the presence of correlated prioritized outcomes using generalized pairwise comparisons: A simulation studyJoris Giai, Delphine Maucort-Boulch, Brice Ozenne, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 24, 2015
Statistical monitoring of data quality and consistency in the Stomach Cancer Adjuvant Multi-institutional Trial Group TrialCatherine Timmermans, Erik Doffagne, David Venet, et al.Expert Review of Molecular Diagnostics|March 17, 2011
Integrating biomarkers in clinical trialsMarc Buyse, Stefan Michiels, Daniel J Sargent, et al.Journal of Clinical Epidemiology|April 3, 2024
Restricted Net Treatment Benefit in oncologyMax Piffoux, Brice Ozenne, Mickaël De Backer, et al.Trials|March 25, 2011
Assessment of the consistency and robustness of results from a multicenter trial of remission maintenance therapy for acute myeloid leukemiaMarc Buyse, Pierre Squifflet, Kathryn J Lucchesi, et al.BMC Medical Research Methodology|October 5, 2022
The case against censoring of progression-free survival in cancer clinical trials - A pandemic shutdown as an illustrationCorinne Jamoul, Laurence Collette, Elisabeth Coart, et al.Clinical Colorectal Cancer|April 10, 2010
Comparison of the levogyre and dextro-levogyre forms of leucovorin in a phase III trial of bimonthly LV5FU2 versus monthly 5-fluorouracil and high-dose leucovorin for patients with stage II and III colon cancer (GERCOR C96.1)Isabelle Baumgaertner, Emmanuel Quinaux, Ahmed Khalil, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2013
Use of early tumor shrinkage to predict long-term outcome in metastatic colorectal cancer treated with cetuximabHubert Piessevaux, Marc Buyse, Michael Schlichting, et al.Biometrical Journal. Biometrische Zeitschrift|September 20, 2022
Generalized pairwise comparisons for censored data: An overviewVaiva Deltuvaite-Thomas, Johan Verbeeck, Tomasz Burzykowski, et al.Cancers|September 28, 2023
Trial Design for Cancer Immunotherapy: A Methodological ToolkitEverardo D Saad, Elisabeth Coart, Vaiva Deltuvaite-Thomas, et al.Pageof 21